ATB 107

Known as: ATB-107, ATB107 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2017
01220032017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
The authors present an overview about proteomics studies in Mycobacterium tuberculosis exposed to some anti-tuberculosis drugs… (More)
Is this relevant?
2010
2010
ATB107 is a potent inhibitor of indole-3-glycerol phosphate synthase (IGPS). It can effectively inhibit the growth of clinical… (More)
  • figure 1
  • figure 3
  • figure 2
  • table 1
  • figure 4
Is this relevant?
2009
2009
Tuberculosis (TB) continues to be a major cause of morbidity and mortality worldwide. The increasing emergence and spread of drug… (More)
Is this relevant?
2007
2007
Miller EJ, Li J, Sinusas KM, Holman GD, Young LH. Infusion of a biotinylated bis-glucose photolabel: a new method to quantify… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2007
2007
Glucose uptake in the heart is mediated by specific glucose transporters (GLUTs) present on cardiomyocyte cell surface membranes… (More)
Is this relevant?
2005
2005
Insulin-stimulated glucose transport is impaired in a genetic model of hypertension, the stroke-prone spontaneously hypertensive… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 5
  • figure 6
Is this relevant?
2004
2004
We evaluated the potential of the Na and Cl -coupled amino acid transporter ATB as a delivery system for amino acidbased prodrugs… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2003
2003
Since their discovery in Germany in 1983 [1], extendedspectrum b-lactamases (ESBLs) have been found worldwide. Typically ESBLs… (More)
Is this relevant?